Growing Demand for Propelling the 2016 Market: 2016 Product Intelligence Market

Albany/New York
Pune/India, April, 2017.

Marketresearchdata.net has added a new report onIndia OTC Drugs Market. The report predicts the market size of India OTC Drugs Market is expected to reach XX billion by 2021.

The report covers the analysis of global as well as regional markets of India OTC Drugs Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

India over the Counter Drugs Market Was worth $6292 million in 2016 and estimated to be growing at a CAGR of 14.6%, to reach $12440 million by 2021. The market is showcasing evident potential in the mentioned forecasting period. Non-Prescription drugs are drugs that are sold over the counter, which means which means that they can be sold without a doctor’s prescription.  They can also be referred as Over-the-Counter (OTC) drugs. There are wide number of therapeutic applications for OTC drugs ranging from weight control drugs to analgesic drugs and many more.
India is the 11th largest market for OTC drugs in the world. Government and different pharmaceuticals companies are taking up various initiatives to create awareness about different drugs and shift Rx to OTC. Urban India is catching up with the notion of OTC drugs due to the advent of technology and advertisements, high work stress levels and increasing health awareness.
Increasing disposable income of the people along with a shift in the consumer attitude towards self-medication and increasing Geriatric population with new social diseases in the region are the two major factors driving the market in the region. Increasing awareness about the cost effectiveness of self-medication and OTC medicines is also a crucial factor fuelling the market growth. However, doctor’s willingness to prescribe OTC and prohibition of advertising for common ailments are the major restraints hindering the growth of the market.
India Over the Counter Drugs market is broadly categorized into Formulation, Product Type and Distribution Channel. On the Basis of formulation, the market is segmented into Liquids, Tablets, Ointments, Sprays and others. Based on Product Type the market is analysed as Analgesics, Cough & Cold preparations, Vitamins and Minerals, Traditional Medicines, Indigestion Preparations and others. Vitamins and minerals is the largest product type accounting for a share of approximately 27% of the total market value followed by Cough and cold medications with a share of around 21%. By distribution channels market is segmented into pharmacies, supermarkets/hypermarkets, Hospital pharmacies and others.
Some of the major companies dominating the market are GlaxoSmithKline, Johnson and Johnson, Dabur India Limited, Sun Pharmaceuticals Limited, Reckitt Benckiser, Bayer Healthcare AG, Emami Limited, Piramal Enterprises, Abbott and Cipla Limited.

Table of Content

1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 KEY DELIVERABLES OF THE STUDY
1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD
1.4 GENERAL STUDY ASSUMPTIONS
2 RESEARCH APPROACH AND METHODOLOGY
2.1 INTRODUCTION
2.1.1 Size Estimation
2.1.2 Forecasting Methodology
2.2 RESEARCH PHASES
2.2.1 Secondary research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 ANALYSIS DESIGN
2.4 STUDY TIMELINE
3 OVERVIEW
3.1 EXECUTIVE SUMMARY
3.2 KEY INFERENCES
4 MARKET DYNAMICS
4.1 MARKET DRIVERS
4.1.1 Shift in Consumer Attitude towards Self-Medication
4.1.2 Rise in Geriatric Population
4.1.3 Rapid Shift from Rx to OTC
4.1.4 Liberalization of OTC Drugs Sales
4.1.5 Affordability of OTC drugs
4.2 MARKET RESTRAINTS
4.2.1 Drug Abuse
4.2.2 Restrictions in Distribution
4.2.3 Therapeutic Errors
4.2.4 Restrictions against Over the Counter antibiotics usage
4.3 CURRENT OPPORTUNITIES
4.3.1 Companies willing to shift to OTC
4.3.2 Widespread use of media venue choices to boost awareness
4.4 KEY CHALLENGES
4.4.1 Trade-offs for lower cost generic prescription drugs
4.4.2 Continued openness towards private-label alternatives
5 MARKET SEGMENTATION
5.1 INTRODUCTION
5.2 INDIA OTC DRUGS MARKET, BY FORMULATION TYPE
5.2.1 Introduction
5.2.2 Tablets
5.2.3 Liquids
5.2.4 Ointments
5.2.5 Sprays
5.2.6 Others
5.3 INDIA OTC DRUGS MARKET, BY PRODUCT TYPE
5.3.1 Introduction
5.3.2 Vitamins and Minerals
5.3.3 Cough and Cold Medications
5.3.4 Traditional Medicines
5.3.5 Analgesics
5.3.6 Indigestion Preparations
5.3.7 Others
5.4 INDIA OTC DRUGS MARKET, BY DISTRIBUTION CHANNEL
5.4.1 Introduction
5.4.2 Pharmacies and Drug Stores
5.4.3 Hospital Pharmacies
5.4.4 Supermarkets
5.4.5 Others
6 STRATEGIC ANALYSES
6.1 PESTLE ANALYSIS
6.1.1 Political
6.1.2 Economical
6.1.3 Social
6.1.4 Technological
6.1.5 Legal
6.1.6 Environmental
6.2 PORTER’S FIVE FORCES ANALYSIS
6.2.1 Threat of New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Suppliers
6.2.4 Bargaining Power of Buyers
6.2.5 Competitive Rivarly
7 MARKET LEADER ANALYSIS
7.1 GLAXOSMITHKLINE PLC
7.1.1 Overview
7.1.2 Products
7.1.3 Financials (in USD Millions)
7.1.4 Recent Developments
7.1.5 SWOT Analysis
7.1.6 Analyst View
7.2 DABUR LIMITED
7.2.1 Overview
7.2.2 Products
7.2.3 Financials (USD Millions)
7.2.4 Recent Developments
7.2.5 SWOT Analysis
7.2.6 Analyst View
7.3 JOHNSON & JOHNSON
7.3.1 Overview
7.3.2 Products
7.3.3 Financials (USD millions)
7.3.4 Recent Developments
7.3.5 SWOT Analysis
7.3.6 Analyst View
7.4 SUN PHARMA
7.4.1 Overview
7.4.2 Products
7.4.3 Financials (USD Millions)
7.4.4 Recent Developments
7.4.5 SWOT Analysis
7.4.6 Analyst View
7.5 RECKITT BENCKISER GROUP PLC
7.5.1 Overview
7.5.2 Products
7.5.3 Financials (USD Millions)
7.5.4 Recent developments
7.5.5 SWOT Analysis
7.5.6 Analyst View
7.6 BAYER HEALTHCARE AG
7.6.1 Overview
7.6.2 Products
7.6.3 Financials (USD Millions)
7.6.4 Recent Developments
7.6.5 SWOT Analysis
7.6.6 Analyst View
7.7 EMAMI LIMITED
7.7.1 Overview
7.7.2 Products
7.7.3 Financials (in USD Millions)
7.7.4 Recent Developments
7.7.5 SWOT Analysis
7.7.6 Analyst View
7.8 PIRAMAL ENTERPRISES
7.8.1 Overview
7.8.2 Products
7.8.3 Financials (USD Millions)
7.8.4 Recent Developments
7.8.5 SWOT Analysis
7.8.6 Analyst View
7.9 ABBOTT LABORATORIES, INC.
7.9.1 Overview
7.9.2 Products
7.9.3 Financials (USD Millions)
7.9.4 Recent Developments
7.9.5 SWOT Analysis
7.9.6 Analyst View
7.1 CIPLA LIMITED
7.10.1 Overview
7.10.2 Products
7.10.3 Financials (USD Millions)
7.10.4 Recent Developments
7.10.5 SWOT Analysis
7.10.6 Analyst View
8 COMPETITIVE LANDSCAPE
8.1 MARKET LEADERS ACROSS TOP SEGMENTS
8.2 COMPETITIVE SCENARIO
8.3 MERGERS & ACQUISITIONS
8.4 COLLABORATIONS, AGREEMENTS & EXPANSIONS
8.5 NEW PRODUCT LAUNCHES
9 MARKET OUTLOOK
To make an enquiry about report visit:

http://marketresearchdata.net/Reports/MakeEnquiryRequest/17436.html

Reasons to buy this report:
1) Deep insights and comprehensive analysis of global and regional markets
2) Complete coverage of key product types and application segments and their sub-segments through geographies and world market
3) Deep dive into the market share and recent developments of the key players in the industry.
4) Analysis and presentation of evolving market trends, patterns, technological advancements
5) Presentation of market dynamics and factors bearing control over the global and regional markets.
6) Competitive landscapes and insights
7) Opportunity mapping in terms of product developments, research and developments and technological advancements.
To know more about us Visit:
http://marketresearchdata.net/Welcome/About.html

Reasons to choose marketresearchdata.net
1) 24X7 sales support and free analyst time for post purchase queries.
2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry
3) Long term relationship management and exclusivity benefits for our clients
 To make sample request for report visit:
http://marketresearchdata.net/Reports/MakeSampleRequest/17436.html

Contact Us:
USA/Canada Toll Free: +18006380796
Rest of the World: +919765091631
Email: sales@marketresearchdata.net
website: http://www.marketresearchdata.net

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s